ANDREA CASTALDI: Open Payments
NPI 1194022285 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 12 payments from 8 companies in 2025. Trend: 2023 $976 · 2024 $941 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $184 |
| AstraZeneca Pharmaceuticals LP | 3 | $176 |
| SANOFI-AVENTIS U.S. LLC | 1 | $150 |
| Merit Medical Systems Inc | 1 | $124 |
| Gilead Sciences, Inc. | 1 | $122 |
| JAZZ PHARMACEUTICALS INC. | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $71 |
| Janssen Biotech, Inc. | 1 | $26 |
Products named: REZUROCK, Savi SCOUT, Trodelvy, ZIIHERA, Enhertu, REBLOZYL, DATROWAY, DARZALEX.
Industry payments across FL — which companies pay providers there.
